Home
Products
Learn
About
Pricing
Log In

What are you looking for?

Home
Pricing
Back
Compare AU

Compare HLTH vs. R3AL

Compare shares and ETFs on the ASX that you can trade on Pearler.

VanEck Global Healthcare Leaders ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Global Healthcare Leaders ETF (HLTH) and the Martin Currie Real Income Fund - Active ETF (R3AL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

HLTH

R3AL

Popularity

Low

N/A

Pearlers invested

57

0

Median incremental investment

$547.55

$0

Median investment frequency

Monthly

N/A

Median total investment

$1,521.84

$0

Average age group

> 35

N/A

Key Summary

HLTH

R3AL

Strategy

HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars.

R3AL.AX was created on 2025-01-28 by Martin Currie. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide a pre-tax income yield above the S&P/ASX 200 Index yield and to grow this income above the rate of Inflation.

Top 3 holdings

Hims & Hers Health Inc Ordinary Shares - Class A (3.17 %)

Corcept Therapeutics Inc (2.67 %)

Tenet Healthcare Corp (2.58 %)

Scentre Group (6.39 %)

Digital Realty Trust Inc (5.67 %)

APA Group (5.43 %)

Top 3 industries

Health Care (100.00 %)

Other (9.10 %)

Real Estate (61.17 %)

Industrials (19.61 %)

Utilities (11.57 %)

Top 3 countries

United States (68.78 %)

Japan (13.50 %)

Denmark (7.34 %)

Management fee

0.45 %

0 %

Key Summary

HLTH

R3AL

Issuer

VanEck

Martin Currie

Tracking index

MarketGrader Developed Markets ex-Australia Health Care Index - AUD

Asset class

ETF

ETF

Management fee

0.45 %

0 %

Price

$11.19

$1.55

Size

$49.651 million

N/A

10Y return

N/A

N/A

Annual distribution yield (5Y)

0.61 %

2.98 %

Market

ASX

ASX

First listed date

09/09/2020

27/01/2025

Purchase fee

$6.50

$6.50

Community Stats

HLTH

R3AL

Popularity

Low

N/A

Pearlers invested

57

0

Median incremental investment

$547.55

$0

Median investment frequency

Monthly

N/A

Median total investment

$1,521.84

$0

Average age group

> 35

N/A

Pros and Cons

HLTH

R3AL

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher distribution yield

Cons

  • Higher management fee

  • Lower distribution yield

  • Lower exposure to US market

HLTH

R3AL

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower distribution yield

Higher distribution yield